Cargando…
Loss of secreted gelsolin enhances response to anticancer therapies
Type 1 conventional dendritic cells (cDC1) play a critical role in priming anticancer cytotoxic CD8(+) T cells. DNGR-1 (a.k.a. CLEC9A) is a cDC1 receptor that binds to F-actin exposed on necrotic cancer and normal cells. DNGR-1 signaling enhances cross-presentation of dead-cell associated antigens,...
Autores principales: | Lim, Kok Haw Jonathan, Giampazolias, Evangelos, Schulz, Oliver, Rogers, Neil C, Wilkins, Anna, Sahai, Erik, Strid, Jessica, Reis e Sousa, Caetano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516286/ https://www.ncbi.nlm.nih.gov/pubmed/36162919 http://dx.doi.org/10.1136/jitc-2022-005245 |
Ejemplares similares
-
Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity
por: Giampazolias, Evangelos, et al.
Publicado: (2021) -
Local anesthetics elicit immune-dependent anticancer effects
por: Bezu, Lucillia, et al.
Publicado: (2022) -
Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses
por: Zhang, Shuai, et al.
Publicado: (2023) -
Oncogenic Transformation of Dendritic Cells and Their Precursors Leads to Rapid Cancer Development in Mice
por: Böttcher, Jan P., et al.
Publicado: (2015) -
Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activity
por: Gammelgaard, Odd L, et al.
Publicado: (2022)